© 2022 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Neal Bhatia, MD, discusses atopic dermatitis and the treatment process, as well as how to improve access to therapies for patients with this disease.
May 20th 2022
Neal Bhatia, MD, provides an overview of atopic dermatitis (AD) and the diagnostic process, as well as how its severity impacts the patient.
Dr Neal Bhatia explains the available treatment options for patients with AD, including their relation to guideline recommendations.
May 31st 2022
A dermatology expert highlights the role JAK inhibitors play in AD therapy, from mechanism of action to ruxolitinib and the TrUE AD1 and -2 trials.
Dr Bhatia concludes our discussion by outlining what factors physicians should be cognizant of when prescribing therapies to patients with AD.